摘要
由人类ether--àgo-go相关基因(HERG)编码的钾离子通道在人类生理、病理过程中扮演着十分重要的角色。在心肌细胞中,HERG钾通道影响心脏动作电位的复极过程,是绝大多数能引起心肌细胞QT间期延长药物的作用靶标,它已成为新药研发早期,评价候选化合物心脏毒性的分子靶标。
The K^+ channel encoded by the human ether-à-go-go related gene(HERG) plays a very important role in human physiological and pathological processes. HERG potassium channel determines the outward currents which facilitate the repolarization of the myocardial cells. Blockade of HERG channel usually results in a long QT interval and serious arrhythmia. Thus, HERG potassium channel has become a valuable target for screening leading compounds for QT interval prolongation in drug development program.
出处
《军事医学科学院院刊》
CSCD
北大核心
2005年第4期386-389,共4页
Bulletin of the Academy of Military Medical Sciences
基金
国家自然科学基金资助项目(30371677)
关键词
HERG
QT间期延长
药物评价
钾通道
HERG
QT interval prolongation
drug evaluation
potassium channels